Mammographic densities during the menopausal transition: A longitudinal study of Australian-born women

Menopause

Volumn 14, Issue 2, 2007, Pages 208-215

  Guthrie, Janet R ^a   Milne, Roger L ^a   Hopper, John L ^a   Cawson, Jennifer ^a   Dennerstein, Lorraine ^a   Burger, Henry G ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Breast; Hormones; Mammographic density; Menopause

Indexed keywords

HORMONE BINDING PROTEIN; TESTOSTERONE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; AUSTRALIA; BLOOD SAMPLING; BODY MASS; BREAST; CLIMACTERIUM; CONTROLLED STUDY; FEMALE; HORMONAL THERAPY; HUMAN; INTERVIEW; LONGITUDINAL STUDY; MAMMOGRAPHY; MULTIVARIATE ANALYSIS; POSTMENOPAUSE; PROTEIN BLOOD LEVEL; TESTOSTERONE BLOOD LEVEL;

AGE FACTORS; AGED; BODY MASS INDEX; BREAST; BREAST NEOPLASMS; COHORT STUDIES; ESTRADIOL; FEMALE; HUMANS; LONGITUDINAL STUDIES; MAMMOGRAPHY; MENOPAUSE; MIDDLE AGED; VICTORIA;

EID: 34247610477     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.gme.0000232278.82218.1f     Document Type: Article

References (32)

1. Ingleby H, Gerson-Cohen J. Comparative Anatomy, Pathology and Roentgenology of the Breast. Philadelphia: University of Philadelphia Press, 1960.
2. Kato I, Beinart C, Bleich A, Su S, Kim M, Toniolo PG. A nested case-control study of mammographic patterns, breast volume, and breast cancer (New York City, NY, United States). Cancer Causes Control 1995;6:431-438.
3. Byrne C, Schairer C, Wolfe J, et al. Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst 1995;87:1622-1629.
4. Boyd NF, Byng JW, Jong RA, et al. Quantitative classification of mammographic densities and breast cancer: results from the Canadian National Breast Screening Study. J Natl Cancer Inst 1995;87:670-675.
5. Brisson J, Merletti F, Sadowsky NL. Mammographic features of the breast and breast cancer risk. Am J Epidemiol 1982;115:428-437.
6. Brisson J, Morrison AS, Kopans DB. Height and weight, mammographic features of breast tissue, and breast cancer risk. Am J Epidemiol 1984;119:371-381.
7. Brisson J, Verreault R, Morrison A, Tennina S, Meyer F. Diet, mammographic features of breast tissue, and breast cancer risk. Am J Epidemiol 1989;130:14-24.
8. Wolfe JN, Saftlas AF, Salane M. Mammographic parenchymal patterns and quantitative evaluation of mammographic densities: a case-control study. AJR Am J Roentgenol 1987;148:1087-1092.
9. Saftlas AF, Hoover RN, Brinton LA, et al. Mammographic densities and risk of breast cancer. Cancer 1991;67:2833-2838.
10. Boyd NF, Byng JW, Jong RA, et al. Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J Natl Cancer Inst 1995;87:670-675.
11. Boyd NF, Greenberg C, Lockwood G, et al. Effects at two years of a low-fat, high-carbohydrate diet on radiologic features of the breast: results from a randomized trial. J Natl Cancer Inst 1997;89:488-496.
12. Spicer DV, Ursin G, Parisky YR, et al. Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk. J Natl Cancer Inst 1994;86:431-436.
13. Struewing JP, Hartge P, Wacholder S, et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 1997;336:1401-1408.
14. Sendag F, Cosan Terek M, Ozener S, et al. Mammographic density changes during different postmenopausal hormone replacement therapies. Fertil Steril 2001;76:445-450.
15. Colacurci N, Forna F, De Franciscis P, Mele D, Palermo M, del Vecchio W. Effects of short-term suspension of hormone replacement therapy on mammographic density. Fertil Steril 2001;76:451-455.
16. Boyd NF, Lockwood GA, Byng JW, Trichler DL, Yaffe MJ. Mammographic densities and breast cancer risk. Cancer Epidemiol Biomarkers Prev 1998;7:1133-1144.
17. Guthrie JR, Dennerstein L, Taffe JR, Lehert P, Burger HG. The menopausal transition: a 9-year prospective population-based study. The Melbourne Women's Midlife Health Project. Climacteric 2004;7:375-389.
18. Burger HG, Dudley EC, Hopper JL, et al. The endocrinology of the menopausal transition: a cross-sectional study of a populationbased sample. J Clin Endocrinol Metab 1995;80:3537-3545.
19. Byng JW, Yaffe MJ, Jong RA, et al. Analysis of mammographic density and breast cancer risk from digitized mammograms. Radiographics 1998;18:1587-1598.
20. Soules MR, Sherman S, Parrott E, et al. Executive summary: stages of reproductive aging workshop (STRAW). Fertil Steril 2001;76:874-878.
21. Stata Statistical Software, release 8. Stata Corporation, College Station, TX, 2001.
22. Guthrie JR, Dennerstein L, Taffe JR, et al. Central abdominal fat and endogenous hormones during the menopausal transition. Fertil Steril 2003;79:1335-1340.
23. Boyd NF, Martin LJ, Stone J, et al. A longitudinal study of the effects of menopause on mammographic features. Cancer Epidemiol Biomarkers Prev 2002;11:1048-1053.
24. Boyd NF, Stone J, Martin LJ, et al. The association of breast mitogens with mammographic densities. Br J Cancer 2002;87:876-882.
25. Burger HG, Dudley EC, Cui J, Dennerstein L, Hopper JL. A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition. J Clin Endocrinol Metab 2000;85:2832-2838.
26. Dimitrakakis C, Zhou J, Bondy CA. Androgens and mammary growth and neoplasia. Fertil Steril 2002;77(Suppl 4):S26-S33.
27. MacDougal OA, Lane MD. Transcriptional regulation of gene expression during adipocyte differentiation. Annu Rev Biochem 1995;64:345-373.
28. Rebuffe-Scrive M, Andersson B, Olbe L, et al. Metabolism of adipose tissue in intra-abdominal depots of non-obese men and women. Metabolism 1989;38:453-458.
29. Boyd NF, Rommens JM, Vogt K, et al. Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol 2005;6:798-808.
30. Burger HG, Dudley E, Hopper JL, et al. Prospectively measured levels of serum FSH, estradiol and the dimeric inhibins during the menopausal transition in a population-based cohort of women. J Clin Endocrinol Metab 1999;84:4025-4030.
31. Berrino F, Bellati C, Secreto G, et al. Reducing bioavailable sex hormones through a comprehensive change in diet: the diet and androgens (DIANA) randomized trial. Cancer Epidemiol Biomarkers Prev 2001;10:25-33.
32. Labrie F, Luu-The V, Lin SX, et al. Intracrinology: role of the family of 17β-hydroxysteroid dehydrogenases in human physiology and disease. J Mol Endocrinol 2000;25:1-16.